Last price paid | 1.70 | |
Change | +6.25% [ +0.10 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 14.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 19.02.2014 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | n.a. |
Year to date (YTD) | -23.77% |
1 month | +14.86% |
3 months | -5.03% |
1 year | -19.05% |
3 years | n.a. |
Issue price | 3.29 |
Underlying price on issue | 1.23 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH0229547994 |
Symbol | IEURE |
Security | 22954799 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | EUR/CHF Wechselkurs |
Underlying ISIN | EU0009654078 |
Funding level | 1.120870 |
Stop-loss level | 1.100540 |
Distance to stop-loss level | n.a. |
Long/Short type | Short |
Subscription ratio | 0.10 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 12.02.2014 |
Premium | n.a. |
Premium p.a. | n.a. |
Leverage | n.a. |
Moneyness | out-of-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | n.a. |
Break-even | n.a. |
SSPA value at risk | 16.87% |
SSPA risk rating |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
UBS | 27.28 |
Givaudan | 4'339.00 |
Lonza Group | 484.30 |
GEBERIT N | 546.60 |
ABB Ltd | 50.28 |
Name | Price |
---|---|
NOVARTIS N | 93.87 |
ROCHE GS | 245.70 |
Compagnie Financi... | 143.20 |
LOGITECH INT. | 88.16 |
Nestlé SA | 95.14 |